| SpectraBase Spectrum ID |
DnS2a9FMns8 |
| Name |
1-(1-Phenylprop-2-yl)-4-(4-methoxyphenyl)piperazine |
| Classification |
Amphetamine analog designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
310.204513464 u |
| Formula |
C20H26N2O |
| InChI |
InChI=1S/C20H26N2O/c1-17(16-18-6-4-3-5-7-18)21-12-14-22(15-13-21)19-8-10-20(23-2)11-9-19/h3-11,17H,12-16H2,1-2H3 |
| InChIKey |
LJYSEHALQXUCKG-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
310.441 g/mol |
| Nominal Mass |
310 u |
| Quality |
981 |
| Retention Index |
2617 |
| SMILES |
C=1(N2CCN(C(CC3=CC=CC=C3)C)CC2)C=CC(=CC1)OC |
| SPLASH |
splash10-014i-9770000000-bb4bc4277c65ef7ced36 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(1-phenylprop-2-yl)-4-(4-methoxyphenyl)
1-(4-methoxyphenyl)-4-(1-phenylpropan-2-yl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_009004 |
